Brain medicine
Scientists have developed a custom-made molecule that targets a post-translationally modified kinase linked to Alzheimer’s, improving symptoms in a murine model of the disease [1]. A novel approach to neutralizing proteins MAPK is a family of kinases involved in numerous cellular processes. One member of this family, p38 MAPK, is known to be activated by...